Overview
Motoki Murata practices practicing medicine in Japan.
His clinical expertise encompasses Muscle Atrophy, Melanoma, Neuroendocrine Tumor, and Familial Hypertriglyceridemia.
He is actively involved in clinical research, co-authoring 24 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Motoki Murata
Is Motoki Murata a top-rated expert for Muscle Atrophy?
MediFind is an objective health platform that identifies experts based on real-world data. Motoki Murata is classified as an Experienced expert for Muscle Atrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Motoki Murata participate in research or clinical trials?
Yes. Motoki Murata has published 24 articles and abstracts on conditions like Muscle Atrophy. You can view a list of Motoki Murata's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Familial HypertriglyceridemiaMr. Murata isExperienced. Learn about Familial Hypertriglyceridemia.
- MelanomaMr. Murata isExperienced. Learn about Melanoma.
- Muscle AtrophyMr. Murata isExperienced. Learn about Muscle Atrophy.
- Neuroendocrine TumorMr. Murata isExperienced. Learn about Neuroendocrine Tumor.